tiprankstipranks
Trending News
More News >
Corcept Therapeutics Inc. (CORT)
NASDAQ:CORT
US Market

Corcept Therapeutics (CORT) Cash flow

Compare
1,238 Followers

Corcept Therapeutics Cash Flow

CORT's free cash flow for Q3 2025 was $54.48M. For the 2025 fiscal year, CORT's free cash flow was decreased by $69.00M and operating cash flow was $54.48M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ 198.07M$ 127.04M$ 120.32M$ 167.89M$ 151.97M
Investing Cash Flow
$ -177.60M$ 90.91M$ -114.33M$ 136.13M$ -119.26M
Financing Cash Flow
$ -28.35M$ -148.72M$ -17.28M$ -302.59M$ 12.21M
End Cash Position
$ 127.67M$ 135.55M$ 66.33M$ 77.62M$ 76.19M
Free Cash Flow
$ 195.90M$ 126.90M$ 119.91M$ 167.42M$ 150.73M
Currency in USD

Corcept Therapeutics Cash Flow